Literature DB >> 8732275

Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones.

I P Chessell1, M D Black, W Feniuk, P P Humphrey.   

Abstract

1. In order to characterize somatostatin (SRIF) receptor inhibiting spontaneous firing of rat locus coeruleus neurones, and their transduction mechanism(S), extracellular recordings were obtained from a pontine slice preparation of rat brain containing the locus coeruleus (LC). LC neurones were identified by electrophysiological and pharmacological properties; spontaneous firing (characteristically 0.5-5 Hz) was reversibly and concentration-dependently inhibited by exogenously applied noradrenaline. 2. Spontaneous firing of LC neurones was reversibly and concentration-dependently inhibited by SRIF and the N-terminally extended form, somatostatin-28 (SRIF-28), with EC50 values of 15.1 and 19.4 nM, respectively. The synthetic SRIF analogues (octreotide, MK-678, BIM-23027 and L-362,855) also caused concentration-dependent inhibition of LC neurone firing with a rank order of agonist potencies compatible with actions at a receptor resembling the recombinant sst2 receptor. The putative sst3 selective agonist, BIM-23056, was without agonist or antagonist effect. 3. Addition of 100 nM desipramine significantly increased the efficacy of exogenously applied noradrenaline (EC50 values, 2.96 and 0.13 microM, absence and presence of desipramine, respectively) but did not significantly affect SRIF-induced inhibition (EC50 values, 15.6 and 8.0 nM, respectively). Furthermore, application of phenoxybenzamine (3 microM) abolished responses to NA, but did not affect responses to SRIF (EC50 = 14.1 nM). 4. Application of the cyclic AMP analogue, 8-bromoadenosine-cyclic monophosphate (8-Br-cyclic AMP; 500 microM), significantly increased the spontaneous firing rate of all neurones tested (223 +/- 24% over basal rate). Concentration-effect curves for SRIF constructed in the absence and presence of 8-Br-cyclic AMP had similar threshold concentrations, maxima and EC50 values. 5. Incubation of pontine slices in a modified artificial CSF containing 500 ng ml-1 pertussis toxin (PTX) for 18 h prior to extracellular recording affected neither the spontaneous firing of LC neurones, nor the inhibitory responses to muscimol (EC50 2.2 and 1.2 microM, absence and presence of PTX). However, inhibitory responses to SRIF were markedly attenuated. 6. We conclude that the inhibitory actions of SRIF on spontaneous firing of LC neurones are mediated directly by activation of somatodendritic SRIF receptors, and not indirectly by release of noradrenaline. The SRIF receptors involved appear to couple via a pertussis toxin sensitive G-protein, and elicit their response by a mechanism apparently independent of inhibition of cyclic AMP formation. The agonist profile of several selective and novel SRIF analogues suggests the identity of this receptor to be similar to the recombinant sst2 receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732275      PMCID: PMC1909561          DOI: 10.1111/j.1476-5381.1996.tb15338.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Distribution of somatostatin mRNA in the rat nervous system as visualized by a novel non-radioactive in situ hybridization histochemistry procedure.

Authors:  H Kiyama; P C Emson
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations.

Authors:  R Markstein; K A Stöckli; J C Reubi
Journal:  Neurosci Lett       Date:  1989-09-25       Impact factor: 3.046

3.  Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.

Authors:  R A North; J T Williams; A Surprenant; M J Christie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Somatostatin induces an inward rectification in rat locus coeruleus neurones through a pertussis toxin-sensitive mechanism.

Authors:  M Inoue; S Nakajima; Y Nakajima
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

5.  Adenosine inhibits locus coeruleus neurons: an intracellular study in a rat brain slice preparation.

Authors:  S A Shefner; T H Chiu
Journal:  Brain Res       Date:  1986-02-26       Impact factor: 3.252

6.  Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei.

Authors:  M F Chesselet; T D Reisine
Journal:  J Neurosci       Date:  1983-01       Impact factor: 6.167

7.  Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.

Authors:  E S McKeen; W Feniuk; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

8.  Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man.

Authors:  A Panconesi; P L Del Bianco; G Franchi; B Anselmi; R Andreini
Journal:  Regul Pept       Date:  1987-09

9.  Potassium conductance increased by noradrenaline, opioids, somatostatin, and G-proteins: whole-cell recording from guinea pig submucous neurons.

Authors:  H Tatsumi; M Costa; M Schimerlik; R A North
Journal:  J Neurosci       Date:  1990-05       Impact factor: 6.167

Review 10.  Somatostatin in the central nervous system: physiology and pathological modifications.

Authors:  J Epelbaum
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

View more
  8 in total

1.  Increased GABAergic Efficacy of Central Amygdala Projections to Neuropeptide S Neurons in the Brainstem During Fear Memory Retrieval.

Authors:  Kay Jüngling; Maren D Lange; Hanna J Szkudlarek; Jörg Lesting; Frank S Erdmann; Michael Doengi; Sebastian Kügler; Hans-Christian Pape
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

2.  Evidence that somatostatin sst2 receptors mediate striatal dopamine release.

Authors:  G J Hathway; P P Humphrey; K M Kendrick
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Expression of five somatostatin receptor mRNAs in the human brain and pituitary.

Authors:  V S Thoss; J Pérez; A Probst; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

4.  Colokinetic effect of somatostatin in the spinal defecation center in rats.

Authors:  Kiyotada Naitou; Takahiko Shiina; Hiroyuki Nakamori; Yuuki Sano; Hiroki Shimaoka; Yasutake Shimizu
Journal:  J Physiol Sci       Date:  2017-01-25       Impact factor: 2.781

5.  Pattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in rats.

Authors:  Miriam Goebel; Andreas Stengel; Lixin Wang; Tamer Coskun; Jorge Alsina-Fernandez; Jean Rivier; Yvette Taché
Journal:  Brain Res       Date:  2010-07-15       Impact factor: 3.252

Review 6.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

Review 7.  Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  μ-Opioid receptor desensitization: homologous or heterologous?

Authors:  Javier Llorente; Janet D Lowe; Helen S Sanderson; Elena Tsisanova; Eamonn Kelly; Graeme Henderson; Chris P Bailey
Journal:  Eur J Neurosci       Date:  2012-09-24       Impact factor: 3.386

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.